Literature DB >> 30008834

Dyspnea caused by a giant retroperitoneal liposarcoma: A case report.

Argyrios Ioannidis1, Christos Koutserimpas1, Michael Konstantinidis2, Ioannis Drikos1, Panagiotis Voulgaris1, Nikolaos Economou1.   

Abstract

Liposarcomas are the most common soft tissue tumors with various histological subtypes. They usually appear in the retroperitoneal region of the abdomen, but their symptomatology remains unclear and their diagnosis, as well as treatment challenging. A case of a 55-year-old female patient with dyspnea and light diffuse abdominal pain caused by a giant retroperitoneal liposarcoma is presented. The patient had an unremarkable medical history, while the computed tomography scan revealed a large mass at the right portion of the abdomen, with its upper limits to the lower edge and the gate portion of the liver. The mass was in contact with the right kidney, the inferior vena cava and the right renal vein, causing mild dilation of the right kidney pelvis. Without any evidence of intra-abdominal metastases, the tumor was surgically resected. The histological analysis of the tumor revealed a well-differentiated liposarcoma. The patient had an uneventful recovery and was discharged on the 10th postoperative day. Until today (4 years later) she remains asymptomatic, without any signs of recurrence. The retroperitoneal liposarcoma is a clinical entity with unclear clinical symptoms and the physician should consider including it in the differential diagnosis of a majority of symptoms, such as dyspnea.

Entities:  

Keywords:  abdominal pain; dyspnea; giant liposarcoma; retroperitoneal tumors

Year:  2018        PMID: 30008834      PMCID: PMC6036330          DOI: 10.3892/ol.2018.8791

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


Introduction

Liposarcomas are the most common soft tissue tumors, presenting with a variety of symptoms such as bleeding, weight loss and abdominal pain. They are usually located in the retroperitoneal region (1). The incidence of retroperitoneal liposarcomas vary between 0.07 and 0.2% of all retroperitoneal tumors, while 85% of these tumors are considered malignant (2). A rare case of a 55-year-old female patient with a giant retroperitoneal liposarcoma presented with dyspnea is reported in the present study.

Case report

A 55-year-old female, suffering from dyspnea and light diffuse abdominal pain was referred to our hospital. The symptoms had begun 2 weeks prior to admission. Her past medical history was unremarkable. The patient was stable (blood pressure, 135/950 mmHg; heart rate, 85 beats/min; saturation, 94%; and breathing rate, 13 breaths/min) and afebrile (36.7°C). Clinical examination revealed distended abdomen and a palpable mass extending from the epigastrium to the right pelvic region. The laboratory results showed hematocrit (Hct)=31.2%, and hemoglobin (Hgb)=10,9 g/dl. Plain X-ray views of the abdomen showed deviation of the bowels to the left side. Further imaging with computed tomography (CT) scan, as well as magnetic imaging resonance (MRI) exhibited a solid mass located in the right abdomen, with its central region not absorbing the intravenous contrast, which was attributed to central necrosis or cystic degeneration (Fig. 1). The mass occupied the right portion of the abdomen repulsing sections of the gastrointestinal tract, with its upper borders to the lower edge and gate portion of the liver and lower borders to the right ovary. The size of this mass was calculated to be 23×19×12 cm. The position of the mass was suppressing the anatomical structures and organs away from their natural position. In addition, the tumor was in contact with the right kidney, the inferior vena cava and the right renal vein causing mild dilation of the right pelvis of the kidney. In the pelvis, the mass was in contact with the bladder, the sigmoid colon, as well as the right iliac vessels which were verified as non-obstructed by the compatible intravenous contrast analysis. There was no evidence of intra-abdominal or peritoneal metastases.
Figure 1.

Retroperitoneal liposarcoma appearing as a solid mass (arrow), with its central region not absorbing dye attributed, due to central necrosis or cystic degeneration. The mass was found as a cystic tumor of the retroperitoneal area which extends from the lower edge of the liver to the right ovary and pelvis region.

Surgical excision of the mass was performed through a midline incision (Fig. 2). The patient did not suffer any postoperative complications, had an uneventful recovery and was discharged on the 6th postoperative day. Pathological examination revealed a well-differentiated liposarcoma, without evidence of cellular atypia, while loose fibrous connective tissue between the malignant cells was observed.
Figure 2.

Intraoperative image of the resected specimen.

The patient was followed up in the out-patient clinic with physical examination and imaging (chest/abdominal/pelvic CT) every 6 months for 3 years and then annually for a total of 4 years until today.

Discussion

Retroperitoneal sarcomas are rare malignancies accounting for approximately 15% of all sarcoma cases, while their incidence is 0.3–0.4% per 100,000 individuals (1,2). Liposarcomas account for approximately 40% of retroperitoneal sarcomas making them the most common type, followed by leiomyosarcoma and malignant fibrous histiocytoma, while it is estimated that they comprise 0.07–0.2% of all neoplasms (3–5). Retroperitoneal liposarcomas have a higher incidence in the sixth and seventh decade, while the influence of sex remains unclear (3,5). The present case was a 55-year-old female. About 50% of cases are diagnosed when their size is over 20 cm. The reported case sought medical assistance 2 weeks after the onset of symptoms, while the mass was already 23×19×12 cm. This is due to the fact that the retroperitoneal region offers large spaces for expansion and the symptomatology may present in the late stages (3,5). Additionally, symptoms are usually non-specific, such as flank or abdominal pain, lower extremity swelling or pain, constipation or urinary symptoms (3,5). The reported case suffered mainly from dyspnea, a symptom very rarely associated with these tumors. Of note, most retroperitoneal liposarcomas remain asymptomatic. Liposarcomas have 5 types: Well-differentiated liposarcoma, dedifferentiated liposarcoma, myxoid/round cell liposarcoma, pleomorphic liposarcoma and mixed liposarcoma. Well-differentiated and dedifferentiated liposarcomas are the most commonly observed retroperitoneal ones, while well-differentiated liposarcoma has 3 subtypes: Lipomatous, sclerotic and inflammatory liposarcoma (3,6–8). The reported case is a well-differentiated liposarcoma, which is usually a slow-growing mass with minimum metastatic behavior. Dedifferentiated liposarcomas are either primary or develop from a well-differentiated one, while myxoid/round cell liposarcomas have a high metastatic potential and are aggressive. Mixed liposarcoma are the rarest and have a poor prognosis (3,7). In patients suspected with retroperitoneal sarcoma a pre-treatment biopsy is not usually performed. Retroperitoneal masses are more likely to be liposarcomas than lipomas and therefore it is best to surgically excise them. In patients unfit for surgery or those who are candidates for preoperative radiotherapy and/or chemotherapy or those with metastases a fine-needle aspiration or core-needle biopsy should be performed. In cases that the management would change with a definite diagnosis and percutaneous biopsies have failed, open biopsy should be considered (3,4). Regarding management of these tumors, surgical excision represents the definite treatment, while surgical resection with negative microscopic margins is the most consistent prognostic factor (3,9–16). Surgical treatment of these cases is challenging, since many structures and organs are usually involved and adipocyte differentiation makes it difficult to distinguish the tumor from retroperitoneal fat tissue (17). Additionally, some cases involve unresectable vital structures or resection could lead to increased morbidity (18). In these cases, a biopsy should be considered and preoperative radiotherapy and/or chemotherapy should be performed to preoperatively downstage the tumor (3). Studies evaluating the aggressive surgical resection have reported good results with 5-year local recurrence-free and disease-specific survival rates of 55 and 75%, respectively (12). Due to the potential high difficulty of these operations the open approach is usually preferred. In the reported patient an open approach with midline incision was performed and the tumor was resected with negative microscopic margins (19). Recurrence of these tumors usually occurs within 6 months to 2 years following surgical excision with local recurrence being much more common than distant metastases. Five-year local recurrence rates following complete macroscopic resection are approximately 50% for well-differentiated retroperitoneal liposarcomas. Early diagnosed and operated recurrences have complete excision rates in approximately 90% of cases (20). Therefore, it is crucial to regularly follow up these patients with imaging, such as CT scan and/or MRI (21). It is recommended that patients with low-grade retroperitoneal soft-tissue sarcomas, successfully treated with surgical resection, should have a follow-up physical examination with imaging (chest/abdominal/pelvic CT) every 3 to 6 months for 2 to 3 years, then annually, while for those with high-grade sarcoma, successfully treated with surgical resection, a follow-up physical examination with imaging (chest/abdominal/pelvic CT) every 3 to 6 months for 2 to 3 years, then every 6 months for the next 2 years, and then annually is recommended. The present patient has been followed up (4 years now), according to this protocol, without any signs of recurrence up-to-date (22). In conclusion, retroperitoneal sarcomas are relatively rare tumors that represent a surgical challenge. Surgical resection with negative microscopic margins is the definite treatment. It is of note that the symptomatology is non-specific. The reported patient presented with dyspnea, something extremely rare and not usually reported in the literature. It is therefore crucial for the physician to perform a thorough physical examination and to keep a keen eye for cases such as this.
  21 in total

1.  Retroperitoneal mixed-type liposarcoma showing features of four different subtypes.

Authors:  Akihiro Hosaka; Yukiyoshi Masaki; Kazuki Yamasaki; Fumio Aoki; Katsuyoshi Sugizaki; Eisaku Ito
Journal:  Am Surg       Date:  2008-12       Impact factor: 0.688

2.  Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana.

Authors:  Darja Erzen; Mojca Sencar; Janez Novak
Journal:  J Surg Oncol       Date:  2005-07-01       Impact factor: 3.454

3.  Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.

Authors:  A Elias; L Ryan; A Sulkes; J Collins; J Aisner; K H Antman
Journal:  J Clin Oncol       Date:  1989-09       Impact factor: 44.544

4.  Is there a role for incomplete resection in the management of retroperitoneal liposarcomas?

Authors:  D Shibata; J J Lewis; D H Leung; M F Brennan
Journal:  J Am Coll Surg       Date:  2001-10       Impact factor: 6.113

5.  Retroperitoneal soft tissue sarcomas: prognosis and treatment of primary and recurrent disease in 117 patients.

Authors:  Ingo Alldinger; Qin Yang; Christian Pilarsky; Hans-Detlev Saeger; Wolfram T Knoefel; Matthias Peiper
Journal:  Anticancer Res       Date:  2006 Mar-Apr       Impact factor: 2.480

Review 6.  Tumors and tumor-like conditions of the adipose tissue.

Authors:  T K Das Gupta
Journal:  Curr Probl Surg       Date:  1970-03       Impact factor: 1.909

7.  Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control.

Authors:  Sylvie Bonvalot; Michel Rivoire; Marine Castaing; Eberhard Stoeckle; Axel Le Cesne; Jean Yves Blay; Agnès Laplanche
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

Review 8.  Retroperitoneal liposarcoma: a comprehensive review.

Authors:  Adarsh Vijay; Lakshmi Ram
Journal:  Am J Clin Oncol       Date:  2015-04       Impact factor: 2.339

9.  Retroperitoneal liposarcomas: the experience of a tertiary Asian center.

Authors:  Ser Yee Lee; Brian Kim Poh Goh; Melissa Ching Ching Teo; Min Hoe Chew; Pierce Kah Hoe Chow; Wai Keong Wong; London L P J Ooi; Khee Chee Soo
Journal:  World J Surg Oncol       Date:  2011-02-01       Impact factor: 2.754

10.  Myxoid liposarcoma in a 91-year-old patient.

Authors:  Brandon S Sheffield; Torsten O Nielsen
Journal:  Mol Cytogenet       Date:  2013-11-19       Impact factor: 2.009

View more
  4 in total

1.  Laparoscopic approach to an incidentally found pelvic retroperitoneal liposarcoma: Case report and review.

Authors:  Vincenzo Dario Mandato; Valentina Mastrofilippo; Loredana De Marco; Lorenzo Aguzzoli
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

2.  Primary retroperitoneal liposarcoma with extensive ossification: A case report.

Authors:  Qi Xin; Xingkai Liu; Xiaoyuan Yu; Junfeng Ye; Xiaofan Peng; Mingming Zhou; Ping Zhang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

3.  Giant retroperitoneal liposarcoma: A case report and literature review.

Authors:  Jonas Herzberg; Klaus Niehaus; Konstanze Holl-Ulrich; Human Honarpisheh; Salman Y Guraya; Tim Strate
Journal:  J Taibah Univ Med Sci       Date:  2019-10-11

4.  A systematic review of margin status in retroperitoneal liposarcomas: Does the R0 margin matter?

Authors:  Benjamin Paik; Chin Jin Seo; Joey Wee-Shan Tan; Wen Kai Darryl Juan; Khee Chee Soo; Chin-Ann Johnny Ong; Claramae Shulyn Chia; Jolene Si Min Wong
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.